Login about (844) 217-0978

Craig Whiteford

In the United States, there are 7 individuals named Craig Whiteford spread across 5 states, with the largest populations residing in Maryland, Pennsylvania, Connecticut. These Craig Whiteford range in age from 55 to 75 years old. Some potential relatives include Taylor Whiteford, Craig Whiteford, Helen Reilly. The associated phone number is 410-252-7040, along with 6 other potential numbers in the area codes corresponding to 203, 785, 913. For a comprehensive view, you can access contact details, phone numbers, addresses, emails, social media profiles, arrest records, photos, videos, public records, business records, resumes, CVs, work history, and related names to ensure you have all the information you need.

Public information about Craig Whiteford

Phones & Addresses

Name
Addresses
Phones
Craig Clayton Whiteford
785-456-7699
Craig Clayton Whiteford
301-592-8450
Craig C Whiteford
410-252-7040
Craig Clayton Whiteford
Craig Clayton Whiteford
410-323-3138, 410-532-7461
Craig Clayton Whiteford
203-531-9394
Craig Clayton Whiteford
301-228-3387
Sponsored by TruthFinder

Publications

Us Patents

Diagnosis Of Sepsis

US Patent:
2021008, Mar 25, 2021
Filed:
Oct 8, 2019
Appl. No.:
16/596481
Inventors:
- Franklin Lakes NJ, US
Sha-Sha Wang - Cockeysville MD, US
Keith Thornton - Owing Mills MD, US
Richard L. Moore - Glenville PA, US
William Keating - Reisterstown MD, US
William A. Nussbaumer - Lutherville MD, US
Craig C. Whiteford - York PA, US
International Classification:
C12Q 1/6883
G01N 33/68
G01N 33/569
C12Q 1/6888
Abstract:
Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Diagnosis Of Sepsis

US Patent:
2011010, May 5, 2011
Filed:
May 7, 2010
Appl. No.:
12/776245
Inventors:
James A. Garrett - Baltimore MD, US
Sha-Sha Wang - Cockeysville MD, US
Keith Thornton - Owing Mills MD, US
Richard L. Moore - Glenville PA, US
William Keating - Reisterstown MD, US
William A. Nussbaumer - Lutherville MD, US
Craig C. Whiteford - York PA, US
International Classification:
C40B 30/04
C12Q 1/68
US Classification:
506 9, 435 6
Abstract:
Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Compositions And Methods For The Identification Of A Carbapenemase Gene

US Patent:
7968292, Jun 28, 2011
Filed:
Apr 7, 2008
Appl. No.:
12/098823
Inventors:
Craig C. Whiteford - York PA, US
Charles Yu - Lutherville MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68
C07H 21/02
US Classification:
435 6, 435975, 536 231
Abstract:
Compositions and methods for the rapid and sensitive detection of a carbapenemase in a sample is provided. The compositions include novel primer and probe compositions for use in detecting the presence of this enzyme in a sample, particularly using PCR methods. These primers and probe sets can be used in amplification methods (such as PCR, particularly quantitative PCR) and packaged into kits for use in amplification methods for the purpose of detecting carbapenemase in a test sample, particularly a patient sample, particularly a direct sample. Thus, in one embodiment, the present invention provides for novel oligonucleotide primers set forth in SEQ ID NOs:1, 2, 4, 5, 7, 8, 14, 15, 17, 18, and 20, and the novel oligonucleotide probe sequences set forth in SEQ ID NOs:3, 6, 9, 16, and 19. These sequences can be used in a method of detecting carbapenemase in a sample.

Diagnosis Of Sepsis

US Patent:
2009010, Apr 23, 2009
Filed:
Apr 4, 2008
Appl. No.:
12/098398
Inventors:
Gary Siuzdak - San Diego CA, US
William A. Nussbaumer - Baltimore MD, US
Craig C. Whiteford - York PA, US
Richard L. Moore - Glenville PA, US
International Classification:
C12Q 1/68
G01N 33/53
G01N 33/567
G06G 7/60
US Classification:
435 6, 435 71, 435 72, 703 11
Abstract:
Methods and apparatus for predicting the development of sepsis in a subject at risk for developing sepsis are provided. Features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods and apparatus for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. A plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods and apparatus for diagnosing sepsis in a subject are provided. A plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Diagnosis Of Sepsis

US Patent:
2006024, Nov 2, 2006
Filed:
Apr 14, 2006
Appl. No.:
11/404744
Inventors:
James Garrett - Baltimore MD, US
Sha-Sha Wang - Cockeysville MD, US
Keith Thornton - Owing Mills MD, US
Richard Moore - Glenville PA, US
William Keating - Reisterstown MD, US
William Nussbaumer - Lutherville MD, US
Craig Whiteford - York PA, US
International Classification:
C12Q 1/68
G01N 33/567
G01N 33/53
US Classification:
435006000, 435007200
Abstract:
Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Compositions And Methods For The Identification Of A Carbapenemase Gene

US Patent:
8324364, Dec 4, 2012
Filed:
May 16, 2011
Appl. No.:
13/108365
Inventors:
Craig C. Whiteford - York PA, US
Charles Yu - Lutherville MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C07H 21/04
US Classification:
536 2433
Abstract:
Compositions and methods for the rapid and sensitive detection of a carbapenemase in a sample are provided. The compositions include novel primer and probe compositions for use in detecting the presence of this enzyme in a sample, particularly using PCR methods. These primers and probe sets can be used in amplification methods (such as PCR, particularly quantitative PCR) and packaged into kits for use in amplification methods for the purpose of detecting carbapenemase in a test sample, particularly a patient sample, particularly a direct sample. Thus, in one embodiment, the present invention provides for novel oligonucleotide primers set forth in SEQ ID NOs:1, 2, 4, 5, 7, 8, 14, 15, 17, 18, and 20, and the novel oligonucleotide probe sequences set forth in SEQ ID NOs:3, 6, 9, 16, and 19. These sequences can be used in a method of detecting carbapenemase in a sample.

Diagnosis Of Sepsis

US Patent:
2014014, May 22, 2014
Filed:
Aug 12, 2013
Appl. No.:
13/965038
Inventors:
- Franklin Lakes NJ, US
Sha-Sha Wang - Cockeysville MD, US
Keith Thornton - Owing Mills MD, US
Richard L. Moore - Glenville PA, US
William Keating - Reisterstown MD, US
William A. Nussbaumer - Lutherville MD, US
Craig C. Whiteford - York PA, US
Assignee:
Beckton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68
US Classification:
435 612
Abstract:
Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Diagnosis Of Sepsis

US Patent:
2016016, Jun 16, 2016
Filed:
Sep 10, 2015
Appl. No.:
14/850933
Inventors:
- Franklin Lakes NJ, US
Sha-Sha Wang - Cockeysville MD, US
Keith Thornton - Owing Mills MD, US
Richard L. Moore - Glenville PA, US
William Keating - Reisterstown MD, US
William A. Nussbaumer - Lutherville MD, US
Craig C. Whiteford - York PA, US
International Classification:
C12Q 1/68
G01N 33/68
Abstract:
Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

FAQ: Learn more about Craig Whiteford

How is Craig Whiteford also known?

Craig Whiteford is also known as: Craig T Whiteford, Graig I Witeford. These names can be aliases, nicknames, or other names they have used.

Who is Craig Whiteford related to?

Known relatives of Craig Whiteford are: Dawn Whiteford, Jamie Whiteford, Cheryl Whiteford, Amanda Farmer, Dawn Yambor, James Lufrano, Jim Lufrano. This information is based on available public records.

What are Craig Whiteford's alternative names?

Known alternative names for Craig Whiteford are: Dawn Whiteford, Jamie Whiteford, Cheryl Whiteford, Amanda Farmer, Dawn Yambor, James Lufrano, Jim Lufrano. These can be aliases, maiden names, or nicknames.

What is Craig Whiteford's current residential address?

Craig Whiteford's current known residential address is: 1713 Meredith Rd, Virginia Beach, VA 23455. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Craig Whiteford?

Previous addresses associated with Craig Whiteford include: 204 River W, Greenwich, CT 06831; 25 Buena Vista Dr, Greenwich, CT 06831; 1001 Laramie St #3, Manhattan, KS 66502; 1007 Walnut St, Wamego, KS 66547; 334 N Delaware Ave, Manhattan, KS 66502. Remember that this information might not be complete or up-to-date.

Where does Craig Whiteford live?

Virginia Beach, VA is the place where Craig Whiteford currently lives.

How old is Craig Whiteford?

Craig Whiteford is 75 years old.

What is Craig Whiteford date of birth?

Craig Whiteford was born on 1949.

What is Craig Whiteford's telephone number?

Craig Whiteford's known telephone numbers are: 410-252-7040, 203-531-9394, 785-537-1815, 913-456-7699, 785-456-7699, 301-592-8450. However, these numbers are subject to change and privacy restrictions.

How is Craig Whiteford also known?

Craig Whiteford is also known as: Craig T Whiteford, Graig I Witeford. These names can be aliases, nicknames, or other names they have used.

People Directory:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z